Unearthing Three Promising Small Cap Stocks in Asia
Top 10 Undiscovered Gems With Strong Fundamentals In Asia
Name
Debt To Equity
Revenue Growth
Earnings Growth
Health Rating
Xuchang Yuandong Drive ShaftLtd
0.03%
-13.23%
-30.14%
★★★★★★
TCM Biotech International
2.98%
5.76%
-0.13%
★★★★★★
Showbox
NA
10.08%
7.87%
★★★★★★
Suzhou Sepax Technologies
0.04%
21.44%
34.83%
★★★★★★
Hokkan Holdings
66.84%
-5.71%
18.42%
★★★★★☆
Nikko
29.66%
6.43%
-3.15%
★★★★★☆
Hong Leong Finance
0.07%
6.89%
6.61%
★★★★★☆
KC
2.19%
8.76%
-0.47%
★★★★★☆
Huang Hsiang Construction
268.99%
13.29%
10.70%
★★★★☆☆
Shanghai Material Trading
3.58%
-6.74%
-5.92%
★★★★☆☆
Click here to see the full list of 2608 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener.
We're going to check out a few of the best picks from our screener tool.
Zhejiang Cheng Yi Pharmaceutical
Simply Wall St Value Rating: ★★★★★☆
Overview: Zhejiang Cheng Yi Pharmaceutical Co., Ltd. operates in the pharmaceutical industry and has a market cap of CN¥4.15 billion.
Operations: Cheng Yi Pharmaceutical generates revenue from its operations in the pharmaceutical industry, with a market capitalization of CN¥4.15 billion.
Zhejiang Cheng Yi Pharmaceutical, with its robust earnings growth of 37.2% over the past year, outperformed the broader Pharmaceuticals industry, which saw a -2.5% change. Despite a volatile share price recently, it trades at 31.3% below estimated fair value, suggesting potential undervaluation. The company reported net income of CNY 200.7 million for 2024 and basic earnings per share rose to CNY 0.61 from CNY 0.50 last year, reflecting strong financial health despite an increased debt-to-equity ratio from 1.3% to 14.9%. A notable one-off gain of CN¥60 million also influenced recent results positively.
Get an in-depth perspective on Zhejiang Cheng Yi Pharmaceutical's performance by reading our health report here.
Gain insights into Zhejiang Cheng Yi Pharmaceutical's historical performance by reviewing our past performance report.
Moon Environment TechnologyLtd
Simply Wall St Value Rating: ★★★★★★
Overview: Moon Environment Technology Co., Ltd. engages in the refrigeration and air conditioning industry both within China and internationally, with a market capitalization of CN¥11.70 billion.
Operations: Moon Environment Technology Co., Ltd. generates revenue through its operations in the refrigeration and air conditioning sectors, serving both domestic and international markets. The company has a market capitalization of CN¥11.70 billion.
Moon Environment Technology, a small player in the machinery sector, offers an intriguing mix of financial metrics. Despite a 10.7% negative earnings growth last year, the company is projected to boost earnings by 12.71% annually. Trading at 41.3% below its estimated fair value suggests potential upside for investors seeking undervalued opportunities. The debt-to-equity ratio has improved significantly from 25.5% to 14% over five years, reflecting prudent financial management with more cash than total debt on hand and positive free cash flow reported consistently. Recent events include a stock split and dividend approval, indicating shareholder-friendly policies amidst executive changes and updated bylaws.
Delve into the full analysis health report here for a deeper understanding of Moon Environment TechnologyLtd.
Gain insights into Moon Environment TechnologyLtd's past trends and performance with our Past report.
Hamaton Automotive Technology
Simply Wall St Value Rating: ★★★★★★
Overview: Hamaton Automotive Technology Co., Ltd is a global manufacturer and supplier of automotive products, with a market capitalization of CN¥5.29 billion.
Operations: Hamaton Automotive Technology generates revenue primarily from its car parts segment, which contributed CN¥1.07 billion.
Hamaton Automotive Technology, a small cap player in the auto components sector, showcases a robust financial profile. Over the past five years, its earnings have grown an impressive 22.2% annually, while maintaining a healthy debt-to-equity ratio that has significantly decreased from 49.7% to just 1%. The company also enjoys high-quality earnings and positive free cash flow. Recent performance highlights include net income of CNY 123.62 million for 2024 and a first-quarter net income of CNY 36.93 million in 2025, reflecting solid operational efficiency despite slightly lower quarterly sales compared to last year.
Click to explore a detailed breakdown of our findings in Hamaton Automotive Technology's health report.
Learn about Hamaton Automotive Technology's historical performance.
Summing It All Up
Click here to access our complete index of 2608 Asian Undiscovered Gems With Strong Fundamentals.
Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Want To Explore Some Alternatives?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SHSE:603811 SZSE:000811 and SZSE:300643.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Spotlight On Promising Penny Stocks In July 2025
As the U.S. stock market continues to reach new highs, with the S&P 500 and Nasdaq setting records, investors are keenly observing opportunities beyond the major indices. For those willing to explore outside of well-known names, penny stocks—often representing smaller or newer companies—remain a relevant investment area despite their somewhat outdated label. This article will spotlight three penny stocks that exhibit financial strength and potential for growth, offering intriguing possibilities for investors seeking hidden value in quality companies. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating ATRenew (RERE) $3.37 $810.62M ★★★★★★ Waterdrop (WDH) $1.98 $658.23M ★★★★★★ CuriosityStream (CURI) $4.55 $268.34M ★★★★★★ WM Technology (MAPS) $0.951 $164.19M ★★★★★★ Perfect (PERF) $2.48 $259.71M ★★★★★★ Tuniu (TOUR) $0.9326 $100.75M ★★★★★★ Cardno (COLD.F) $0.1701 $6.64M ★★★★★★ BAB (BABB) $0.886 $6.1M ★★★★★★ Lifetime Brands (LCUT) $4.72 $109.16M ★★★★★☆ Tandy Leather Factory (TLF) $3.47 $29.28M ★★★★★★ Click here to see the full list of 412 stocks from our US Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. PetMed Express Simply Wall St Financial Health Rating: ★★★★★★ Overview: PetMed Express, Inc., along with its subsidiaries, operates as a pet pharmacy in the United States and has a market cap of approximately $77.56 million. Operations: The company generates revenue through its online retail operations, amounting to $247.01 million. Market Cap: $77.56M PetMed Express, Inc. operates with a market cap of US$77.56 million and generates revenue of US$247.01 million through its online pet pharmacy services. Despite becoming profitable recently, the company faces challenges including a large one-off loss impacting recent financial results and an inexperienced board and management team with average tenures of 2.2 and 1.1 years, respectively. The company's short-term assets exceed both its short- and long-term liabilities, indicating solid liquidity despite no debt concerns. Recent delays in SEC filings have led to Nasdaq compliance issues but do not currently affect trading activities or stock listing status. Dive into the specifics of PetMed Express here with our thorough balance sheet health report. Learn about PetMed Express' future growth trajectory here. Mega Matrix Simply Wall St Financial Health Rating: ★★★★★★ Overview: Mega Matrix Inc. operates a streaming platform called FlexTV, specializing in vertical screen entertainment, with a market cap of $107.33 million. Operations: The company's revenue is primarily derived from the Asia-Pacific region ($17.26 million), followed by the United States and Canada ($11.66 million), Europe, Middle East and Africa ($4.54 million), and Latin America ($1.76 million). Market Cap: $107.33M Mega Matrix Inc., with a market cap of US$107.33 million, operates FlexTV, focusing on vertical screen entertainment. The company is unprofitable but maintains a strong cash runway exceeding three years and has no debt. Its recent strategic alliance with Wardour Studios to form AIFLIX LLC aims to leverage AI for short drama production, potentially enhancing its content offerings and global reach. Despite increased volatility and declining sales from US$8.69 million to US$7.74 million year-over-year, the appointment of seasoned investor Yaman Demir as an executive director may bolster its strategic direction in digital assets and innovation initiatives. Click here to discover the nuances of Mega Matrix with our detailed analytical financial health report. Evaluate Mega Matrix's historical performance by accessing our past performance report. Tilly's Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Tilly's, Inc. is a specialty retailer in the United States offering casual apparel, footwear, accessories, and hardgoods for young men and women as well as boys and girls, with a market cap of $49.15 million. Operations: The company generates revenue from its retail segment focused on apparel, totaling $561.21 million. Market Cap: $49.15M Tilly's, Inc., with a market cap of US$49.15 million, has faced challenges as evidenced by its removal from multiple Russell indices. Despite generating US$561.21 million in revenue from its retail segment, the company remains unprofitable with losses increasing over the past five years. Its short-term assets of US$127 million exceed short-term liabilities but fall short of covering long-term liabilities of US$138.5 million. The management and board are experienced, averaging over 10 years tenure each, while the company benefits from being debt-free and trading at good value compared to peers despite high volatility and negative return on equity. Take a closer look at Tilly's potential here in our financial health report. Examine Tilly's earnings growth report to understand how analysts expect it to perform. Seize The Opportunity Click here to access our complete index of 412 US Penny Stocks. Want To Explore Some Alternatives? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include PETS MPU and TLYS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
28 minutes ago
- Yahoo
Broadcom's record, Charter's Q2 miss, Newmont's buyback plan
Market Domination host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute. Broadcom (AVGO) stock extends gains after hitting a record high, with the chipmaker outperforming nearly all of the "Magnificent Seven" stocks this year, second only to Nvidia (NVDA). Charter Communications (CHTR) stock sinks after a second quarter earnings miss and a larger-than-expected loss of residential internet customers. Newmont (NEM) beats second quarter expectations and posts record-high free cash flow, while also announcing a $3 billion share buyback program. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. It's time for your finance's market minute. Broadcom shares on track to hit another high on Friday, it's after closing at a record in the previous trading session. Semiconductor company has largely outperformed the magnificent seven stocks over the past year. So far, this year, the only magnificent seven stock to outperform Broadcom would be Nvidia. And shares of Charter communications, they're sinking in today's trade, the company missing earnings estimates for the second quarter. Charter communications also lost more residential high-speed internet customers than was expected. And lastly, Newmont reporting second quarter earnings and sales that did top expectations, the precious metals minor generating an all-time record quarterly free cash flow. Company also green lighting an additional $3 billion share repurchase program. And that's your Yahoo Finance Market Minute. For more on what's trending on Yahoo Finance, scan the QR code below to track the best and worst performing stocks of the session.


The Verge
31 minutes ago
- The Verge
Anker is no longer selling 3D printers
In March, charging giant Anker announced it would spin out its 3D printer business into an 'independent sub-brand,' stating that the new EufyMake would 'continue to provide comprehensive customer service and support' for its original 3D printers the AnkerMake M5 and M5C. Now, the 3D printing community is wondering whether that was all a euphemism for exiting the 3D printer business. eufyMake is no longer selling any 3D printers and has stopped selling some of the parts it would need to provide anything close to 'comprehensive support.' Anker confirms to The Verge that it has stopped selling the M5 and M5C 3D printers indefinitely. Spokesperson Brett White could not confirm that the company will resume selling them or create any future models. He says that 'sales have been paused.' 'My understanding is that eufyMake has not ruled out creating new 3D printer models in the future. But the brand has ended sales of the M5 and M5C for the time being,' White tells The Verge. The 3D printing section of EufyMake's website is currently empty of printers. The only gadget EufyMake now sells is a UV printer that creates a 3D texture atop flat materials. To put it mildly, Anker had a rough start in the 3D printer business. It set out to fix big pain points with 3D printing with the original M5, but ran into many issues that I documented in my original review. The M5C was both more affordable and better appreciated by the community but sacrificed features like a dedicated screen. Makers ran into their share of issues with it too. Now, Redditors are also reporting they can no longer easily obtain the most critical parts for the M5C — the hotend that melts and deposits the plastic. 'Due to inventory reasons, the M5C hot end has been removed from the official website and is no longer available for purchase,' reads an alleged email from EufyMake support to one Redditor (hit the right arrow twice to see the screenshot): 'So my entire 3D printer is garbage because you stopped supporting it?' the Redditor replied. (Hotends are often one of the first components you replace if or typically when a 3D printer jams.) Anker also appears to have stopped selling the full extruder assembly for the M5C. I feel for you if you bought one of these printers. 'A portion of the AnkerMake accessories for 3D printers are no longer publicly listed for sale, but customers can always reach out to the customer support team directly by emailing support@ if they need any related accessories,' White tells The Verge. He says he'll look into the specifics of M5C hotend and extruder availability for us. Anker isn't the only company that's had difficulty moving into the next, more consumer-friendly and affordable phase of the 3D printing business. Creality also had a mess on its hands with the K1, a printer designed to compete with the AnkerMake M5, though it recovered from some of its issues by quickly moving to new and improved models. Today, the friendliest 3D printers I can recommend are the Bambu P1S and P1P, and the Elegoo Centauri Carbon, which doesn't offer all the same conveniences of Bambu, but meets the P1 series' print quality, adds a touchscreen, and starts at an incredibly low price of $300. I've been testing my own personally owned P1P against Bambu's flagship H2D and a Centauri Carbon. While using the Bambu is faster and easier, especially with an AMS attached, I would happily buy the Elegoo if I were more concerned about the Bambu update controversy. Posts from this author will be added to your daily email digest and your homepage feed. See All by Sean Hollister Posts from this topic will be added to your daily email digest and your homepage feed. See All Gadgets Posts from this topic will be added to your daily email digest and your homepage feed. See All Report Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech